Operations staff from some of BioForward’s largest companies participated in a virtual panel to provide guidance to smaller companies to help outline what processes, procedures, and best practices should be implemented in dealing with COVID-19.
Participants included Eurofins, Illumina, Exact Sciences, Promega, Gilson, Covance, and Catalent. They also have sent along templates and documents that will provide a good starting place for those lacking the resources or experience to already have them in place. Please let us know if you have anything to add.
As part of BIO’s broader efforts to ensure critical research and development programs continue during these challenging times, they have created the Coronavirus Hub. They have heard and seen many requests from medical research centers, biopharmaceutical companies, testing developers and testing sites requesting supplies and inquiring about manufacturing capacity. This site enables users to post requests, announce the availability of supplies and capacity and to respond to those requests and announcements.
The Biotechnology Innovation Organization has a podcast series sharing powerful stories about biotechnology breakthroughs. Listen direct from biopharma on how they are meeting the challenges of rapidly and safely bringing forward new vaccines and therapies for the coronavirus.
All of us at BioForward are evaluating both short- and long-term plans in response to the changing conditions surrounding the spread of the novel coronavirus, and we know our members are too-- we know member companies are actively responding as employers by developing policies to limit the spread of the disease and protect their employees. Here are some tips about laws and best practices for those who need them.
Harvard Business Review Operations Management key suggestions about maintaining your supply chain during adverse situations based off of past emergencies.
U.S. Chamber of Commerce Foundation has developed a resilience program based on best practices designed to educate business leaders on disaster preparedness and business resilience.
BIO has launched a new Coronavirus Hub that connects those companies that have relevant supplies, capacities, and resources to share, with those companies, researchers, or healthcare providers that need them.
Baker Tilly has launched a high value, free tool that can help you assess the current impact of the crisis on your organization, understand your level of preparedness, and uncover and mitigate potential risks.
The World Health Organization has prepared a “Strategic Preparedness and Response Plan” for businesses dealing with coronavirus concerns.
Laughlin Constable informs businesses how to be a reliable source of information, communicate action and preparedness, and they provide PR and marketing tips about how to present your company in a positive light.
Baker Tilly has recorded a video with the CEO and prepared a resource center to help organizations with stability and preparedness support for their employees, customers and supply chain.
Baker Tilly is well positioned to negotiate and help with some key issues specifically affecting the medical device and pharmaceutical areas. They also have a great webinar series to help businesses.
The Medical College of Wisconsin has prepared a “Business Continuity Considerations” PDF for businesses dealing with coronavirus concerns.
Flad has provided this useful document to help companies learn more about their spaces and pandemic response.
Marshfield Clinic Health System has established a fund to provide financial resources quickly to local community organizations who can help “flatten the curve” by addressing local needs and issues associated with the coronavirus.
Wisconsin Economic Development Corporation will begin accepting applications online for the $75 million “We’re All In” Small Business Grant program beginning on June 15.
Pfizer’s new program will invest up to $500 million in biotechnology companies to help provide funding and access to Pfizer’s scientific expertise to ensure continuity of the biotechnology companies’ most promising clinical development programs.
BioForward is proud of our members and the abundance of knowledge and resources they are putting towards this effort both locally and globally. The Wisconsin biohealth industry has a wealth of top talent working on the front line because we know they can and will save lives. Below is a list of local companies and how they are responding. Update us on your efforts and we will add you to the list.